Literature DB >> 18247177

Community physicians' strategies for patients with medically unexplained symptoms.

Matt Anderson1, Arthur Hartz, Terri Nordin, Marcy Rosenbaum, Russell Noyes, Paul James, John Ely, Neeraj Agarwal, Steve Anderson.   

Abstract

BACKGROUND AND OBJECTIVES: This qualitative study examined the management strategies that community primary care physicians use for patients with medically unexplained symptoms (MUS).
METHODS: Volunteer community physicians identified patients with chronic MUS. The physicians and patients were interviewed separately about management strategies used and their effectiveness. Thematic analyses were used to categorize these strategies.
RESULTS: Thirty-six physicians and 49 of their patients completed interviews. Physician strategies considered effective by physicians and patients included medical treatment, exploring causes of symptoms with tests and referrals, attentive listening, validating complaints, demonstrating commitment over time (eg, assuring patients of continued care, allowing extended office visits, and returning phone calls), providing clear explanations of symptoms and management, and providing explanatory models for the linkage between psychosocial factors and physical symptoms. Strategies used that conflict with published recommendations included ordering potentially unnecessary diagnostic tests, scheduling patients on demand, and prescribing narcotics. Physicians expressed concerns about these strategies but considered the benefits for specific patients worth the costs and risks.
CONCLUSIONS: Physicians used some strategies recommended in the medical literature and others not recommended. The ability to effectively implement certain strategies may depend on having a long-term relationship with a patient and a health care environment that permits extensive patient-physician interaction.

Entities:  

Mesh:

Year:  2008        PMID: 18247177

Source DB:  PubMed          Journal:  Fam Med        ISSN: 0742-3225            Impact factor:   1.756


  8 in total

1.  Functional Somatic Symptoms.

Authors:  Casper Roenneberg; Heribert Sattel; Rainer Schaefert; Peter Henningsen; Constanze Hausteiner-Wiehle
Journal:  Dtsch Arztebl Int       Date:  2019-08-09       Impact factor: 5.594

2.  Somatisation and alexithymia in patients with high use of medical care and medically unexplained symptoms.

Authors:  Norman H Rasmussen; David C Agerter; Robert C Colligan; Macaran A Baird; Charles E Yunghans; Stephen S Cha
Journal:  Ment Health Fam Med       Date:  2008-09

3.  [Psychotherapeutic approaches for patients with somatoform disorders].

Authors:  J M Gottschalk; W Rief
Journal:  Nervenarzt       Date:  2012-09       Impact factor: 1.214

4.  Non-specific, functional, and somatoform bodily complaints.

Authors:  Rainer Schaefert; Constanze Hausteiner-Wiehle; Winfried Häuser; Joram Ronel; Markus Herrmann; Peter Henningsen
Journal:  Dtsch Arztebl Int       Date:  2012-11-23       Impact factor: 5.594

5.  Evaluating challenges for improving medically unexplained symptoms in US military veterans via provider communication.

Authors:  L Alison Phillips; Lisa McAndrew; Benjamin Laman-Maharg; Katharine Bloeser
Journal:  Patient Educ Couns       Date:  2017-03-06

6.  A controlled study of the effect of a mindfulness-based stress reduction technique in women with multiple chemical sensitivity, chronic fatigue syndrome, and fibromyalgia.

Authors:  Tara Sampalli; Elizabeth Berlasso; Roy Fox; Mark Petter
Journal:  J Multidiscip Healthc       Date:  2009-04-07

7.  Internists' dilemmas in their interactions with chronically ill patients; A comparison of their interaction strategies and dilemmas in two different medical contexts.

Authors:  Nicolien M H Kromme; Kees T B Ahaus; Reinold O B Gans; Harry B M van de Wiel
Journal:  PLoS One       Date:  2018-05-30       Impact factor: 3.240

8.  Demographic and health-related factors associated with reduced work functioning in people with moderate medically unexplained physical symptoms: a cross-sectional study.

Authors:  Mark L van Tilburg; Paula Elisabeth van Westrienen; Martijn F Pisters
Journal:  BMC Public Health       Date:  2020-08-31       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.